US Stocks

Veracyte, Inc.

Veracyte, Inc. is a global diagnostics company that provides a range of diagnostic tests specifically designed for cancer and other diseases diagnosis. The company has a comprehensive suite of genomic sequencing classifiers such as Afirma, Decipher Prostate Biopsy and Radical Prostatectomy, Prosigna Breast Cancer Assay, Percepta Nasal Swab Test, Envisia Genomic Classifier, and Immunoscore Colon Cancer Test to aid in diagnosing different kinds of cancers. Veracyte, Inc. has technology licensing and collaboration arrangements with various healthcare companies and is headquartered in South San Francisco, California.